2 years ago

Sano Genetics Secures $11.4 Million to Accelerate Precision Medicine Clinical Trials

  • Sano Genetics, a precision medicine software platform, has raised $11.4 million in a Series A round led by Plural

  • The company's software uses AI to manage all aspects of clinical trials, from design to patient recruitment to genetic and other biomarker testing and patient engagement

  • Sano Genetics connects patients across four countries with pharmaceutical and biotech companies conducting clinical trials, making it easier for patients to access precision medical treatment and for companies to bring new, effective drugs to market quickly

  • The company will use the new funding to expand its reach to more countries and integrate LLMs and other AI tools to drive more productivity.

      • ProblemTechnology

      "Running precision medicine clinical trials is complex and time-consuming. It involves finding the right patients, managing their data, and ensuring compliance with regulations. Traditional methods are slow and inefficient, leading to high costs and delays in bringing new drugs to market."

      Solution

      "Sano Genetics is a software platform that uses AI to manage all aspects of precision medicine clinical trials, from design to patient recruitment to genetic and other biomarker testing and patient engagement. The platform helps to streamline the process, making it faster, more efficient, and cost-effective."

      Covered on